BioNexus Gene Lab Corp. Deferred Income Tax Liabilities, Net
BioNexus Gene Lab Corp. (BGLC) had Deferred Income Tax Liabilities, Net of $0 as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2025-11-14
- 2025-09-30: Deferred Income Tax Liabilities, Net $0.00.
- 2025-06-30: Deferred Income Tax Liabilities, Net $0.00.
- 2025-03-31: Deferred Income Tax Liabilities, Net $0.00.
- 2024-12-31: Deferred Income Tax Liabilities, Net $0.00.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-18 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-14 |
| 2024-09-30 | $13.65K 10-Q · filed 2024-11-15 |
| 2024-06-30 | $11.92K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $11.92K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $12.26K 10-K · filed 2025-04-15 |
| 2023-09-30 | $28.88K 10-Q/A · filed 2024-03-26 |
| 2023-06-30 | $29.05K 10-Q · filed 2023-08-16 |
| 2023-03-31 | $30.68K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $30.87K 10-K · filed 2024-04-16 |
| 2022-09-30 | $25.54K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $28.42K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |